SWT VERSUS EMFT IN KOA

NCT07505368 | Completed DMC

• 1 other identifier: SUEZPT2025
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study was to compare the effect of extracorporeal shock wave therapy and pulsed electromagnetic field in reducing pain, improving function, and increasing ROM in knee osteoarthritis patients.

Conditions

Physical Therapy

Keywords

Shock Wave Therapy; Electromagnetic Field Therapy; Knee Osteoarthritis

Outcome Measures

Primary Outcomes (3)

• Change in physical function.

  Measurement of physical function using the Western Ontario and McMaster Universities Osteoarthritis Index.

  Pretreatment measurement and posttreatment (4 weeks) measurement.

• Change in pain intensity

  Measurement of pain intensity using the visual analogue scale.

  Pretreatment measurement and posttreatment (4 weeks) measurement.

• Change in range of motion.

  Measurement of range of motion using the digital goniometer.

  Pretreatment measurement and posttreatment (4 weeks) measurement.

Study Arms (3)

Group A

EXPERIMENTAL

Experimental group 1.

Procedure: Shock Wave Therapy; Procedure: Conservative therapy

Group B

EXPERIMENTAL

Experimental group 2.

Procedure: Electromagnetic Field Therapy; Procedure: Conservative therapy

Group C

EXPERIMENTAL

Experimental group 3.

Procedure: Conservative therapy

Interventions

Shock Wave Therapy PROCEDURE

Electrotherapy application

Group A

Electromagnetic Field Therapy PROCEDURE

Electrotherapy application

Group B

Conservative therapy PROCEDURE

Hot pack, stretching exercises and strengthening exercises

Group A; Group B; Group C

Eligibility Criteria

• Age: 40 Years - 60 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Sixty patients must have a confirmed diagnosis of knee osteoarthritis, specifically those with mild to moderate osteoarthritis.
• Participants must have experienced knee pain lasting more than 3 months.
• Their ages will be ranged from 40 to 60 years.
• Their body mass index within the range of 22.7 to 28.5 kg/m² kg/m².
• Both male and female patients are eligible for the study.
• At least two positive provocative tests, such as joint line tenderness and crepitus, which are commonly associated with knee osteoarthritis.

You may not qualify if:

• Inflammatory arthritis (e.g., rheumatoid arthritis) or other forms of arthritis that are not osteoarthritis.
• Undergone knee replacement surgery or any significant knee surgery within the past year.
• Severe cardiovascular, respiratory, renal, or hepatic diseases that could interfere with study participation or outcomes.
• Received intra-articular corticosteroid injections in the affected knee within the last 3 months.
• Pregnant or breastfeeding due to the unknown effects of study treatments on fetal and infant development.
• Neurological conditions affecting the lower limbs (e.g., stroke, neuropathy). body mass index greater than 30 kg/m², as severe obesity may influence treatment outcomes and complicate assessment.
• Cognitive impairments or psychiatric conditions that may affect their ability to participate.

Sponsors & Collaborators

• Suez Canal University: lead

Study Sites (1)

The Outpatient Clinics, Faculty of Physical Therapy Suez Canal University

Ismailia, Egypt

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Interventions

Extracorporeal Shockwave Therapy; Magnetic Field Therapy; Conservative Treatment

Condition Hierarchy (Ancestors)

Osteoarthritis; Arthritis; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases

Intervention Hierarchy (Ancestors)

Ultrasonic Therapy; Diathermy; Hyperthermia, Induced; Therapeutics; Physical Therapy Modalities; Rehabilitation

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Masking Details: The patients will be blinded regarding which treatment group they were allocated into.
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Maha Mousa Salem

Model Details: Randomized controlled trial

Study Record Dates

• First Submitted: November 17, 2025
• First Posted: April 1, 2026
• Study Start: January 1, 2025
• Primary Completion: December 31, 2025
• Study Completion: March 1, 2026
• Last Updated: April 1, 2026

Record last verified: 2026-03

Data Sharing

• IPD Sharing: Will not share

Locations

EG (1)